Now on Faron’s blog, Bono:
Edit: “Clinically, this may mean, and we have begun to see in the BEXMAB trial, not only anti-tumor activity, but also evidence of improved bone marrow function, including signs of trilineage hematopoietic recovery.”
A fine sentence in itself. Someone wiser might be able to explain the deeper meaning?